Andrew Allen

Insider profile

Currently holds positions in Epizyme Inc, Sierra Oncology Inc and Gritstone Oncology Inc

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Epizyme Inc June 9, 2014 -
Independent Director Sierra Oncology Inc Oct. 23, 2017 -
President, Chief Executive Officer, Director Gritstone Oncology Inc Oct. 1, 2015 -
Andrew Allen's trades of Gritstone Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
220.53
Quantity 53,940 +15.3%
Value US$3,634,579
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-17 2024-05-16
S Sale
53,940 +15.3%
220.53
US$3,634,579 		53,940 +15.3% 220.53 US$3,634,579